Testing effectiveness (Phase 2)Study completedNCT03815812
What this trial is testing
Multiple Ascending Dose Study of PCSK-9 Inhibitor (IBI306) in Chinese Patients With Hypercholesterolemia
Who this might be right for
Hypercholesterolemia
Innovent Biologics (Suzhou) Co. Ltd. 60